ArticleBakar Labs News
News
Latest news115
Tenant Spotlight
Tenant Spotlight on Coagulant, a Company Defying the Odds to Save Lives
“I think anyone who meets me understands my passion for what I’m doing,” Terry says. “I’m not here to make a business per se. I am here to impact people’s lives." Read post
Company News
Granatus Ventures Invests in Endometrics to Develop First-in-Kind Solution to Endometriosis
Endometriosis is a chronic condition that affects women causing severe pain and infertility. It affects around 10% of women of reproductive age, diagnosis takes up to 8 years and requires surgery. Endometrics develops a unique solution for diagnosing endometriosis non-invasively by identifying specific genomic features of endometrial cells. Read post
Company News
Coagulant Therapeutics Announces Publication in Blood Advances Describing Novel Nanobody Library to Activated Protein C and Initial Leads for Treatment of Trauma and Hemophilia
By using assays specific for coagulation, inflammation and cell survival functions of APC, the investigators were able to identify an array of human APC specific antibodies able to retain or eliminate these functions. This represents a tool chest for APC targeted therapies that has already identified a lead candidate for the treatment of trauma and hemophilia. Read post
Company News
Humboldt Fund and Bakar Labs Join Forces to Support World-Changing Startups
“What we look for in a company is impact,” said Francisco Dopazo, General Partner at Humboldt Fund. “We want to fund companies that are solving huge problems for humanity, and just like at Bakar Labs, we’re not only focused on healthcare. We see potential for solutions in a wide range of industries.” Read post
Tenant Spotlight
Tenant Spotlight on Mekonos, a Diverse Team Making Cell Therapies More Accessible
“We’ve been super fortunate to be part of Bakar Labs,” Anil says. “One of our values at Mekonos is learning every day, both on the technical and non-technical side. We’re thankful to have been part of an ecosystem where we can do both.” Read post
Company News
Profluent Announces Launch With $9 Million Seed Round
Profluent is using deep generative models to ‘learn the language of biology’ in order to design new, functional proteins. The goal of protein design is to create novel or enhanced proteins with specific uses. These could include lasting cures for diseases that are free from patent restrictions or new enzymes that can break down unrecyclable plastics. Read post
Tenant Spotlight
Tenant Spotlight on Via Nova Therapeutics & Antiviral Development: Seek Out Investors Whose Aims Align With Yours
“Don and I got to talking and we decided, let's try to get these assets out of Novartis and found Via Nova. A little over a year ago, we were able to execute on a Series A, to get an initial funding of $20 million, which also enabled the in-licensing of the assets from Novartis. The four that we chose are for influenza, human rhinovirus, BK polyomavirus and adenovirus.” Two scientists without a team or a lab raised $20 million? You heard right. That funding came from Aditum Bio, an investment firm founded by former Novartis scientists who could appreciate that millions of dollars had already been invested into the R&D for these assets. Read post
BBH News
MBH Architects & BBH Recognized in Interior Design’s 2022 Best of Year Awards
Interior Design's Best of Year is the design industry's premiere design awards program, honoring the most significant work of the year as well as recognizing designers, architects, and manufacturers from around the globe. Read post
BBH News
BBH Wins Structural Engineering Excellence Award from STRUCTURE Magazine
Congratulations to Forell Elsesser, the engineering firm contracted for the seismic retrofit that turned the former Berkeley Art Museum from a structural liability to the Bakar BioEnginuity Hub, a robust building home to the Bakar Labs incubator! Read post
Company News
Black Sheep Foods Grabs $12.3M to Craft Tastier Plant-Based Meats
Venture capital into the food tech sector has been waning recently. However, by making flavors and also using them, Kumar believes Black Sheep Foods’ new funding is the result of setting the company up for a vertical integration approach that puts it in a unique space done only by Impossible Foods thus far. He adds the new round was planned and follows progress on some of the key things the company has set out to do in 2022, including the rate of product adoption and R&D milestones on its flavors. Read post
Tenant Spotlight
Tenant Spotlight: Reflexion Pharmaceuticals & The Mirror World of D-Therapeutics
CEO Greg Went appreciates that our time on Earth is short. What he cares about is helping patients with medicines that work. He doesn’t have time for the ego that some scientists have tied up in the technologies they’re developing. He admits that, early on, even his company was too into itself. “What Reflexion lacked early on was the mentality of ‘why develop this technology if it’s not better than monoclonal antibodies.’ ‘Same as’: we don’t need that. We need products that are a factor of two to ten times better than the standard of care.” Read post
BBH News
Retrofitting a Classic – Bakar BioEnginuity Hub
Every aspect of our building is innovative! “What we ended up with was this really cool system of ‘stealth’ looking concrete walls,” Price explains. “They had extreme angles – from 45 degrees to 60 degrees, that were top-cast finished with an EcoSand final finish.” Being large stretches of concrete, there was also concern about skateboarders, so a custom stainless-steel system of skateboard deterrence was designed to replicate the human genome and installed on the face of the battered walls. Read post
Company News
At Minutia, Katy Digovich Is Tackling Diabetes Cell by Cell
But while continuing to work in Africa with the Clinton Health Access Initiative, she learned she couldn't get far enough away. People were surprised when they learned that the nearly 6-foot-tall, athletic-looking Digovich — a former basketball player in college — was living with Type 1 diabetes, a diagnosis in Africa that often translates into stunted growth, amputation and high mortality. "Ultimately, I got really angry and the switch flipped. If I was born there, I would be dead. That really hit close to home," she said. "I took stock of my career and threw myself into the diabetes space." Read post
BBH News
BBH Wins 2022 Preservation Design Award for Rehabilitation
The Bakar BioEnginuity Hub is a winner for the 2022 Preservation Design Award for Rehabilitation. Award recipients are selected by a jury of top professionals in the fields of architecture, engineering, planning, and history, as well as renowned architecture critics and journalists. Read post
Company NewsGolden Ticket News
Nosis Bio, Radar Tx, ResVita Bio Win Golden Tickets to Bakar Labs, in Collaboration With AbbVie
The three companies win free lab space for a year, with access to our facilities and UC Berkeley ecosystem, and connections to AbbVie experts and industry-scale resources. Read post
Tenant Spotlight
Tenant Spotlight: Valitor Aligns Its Stakeholders to Develop Biopolymer Therapeutics
“Getting the science right is hard enough, but at least I was trained to be a scientist,” says CSO and former CEO Wesley Jackson. “The skill that I had to learn the quickest was to keep all the company’s stakeholders aligned. I naively assumed that if the science was great enough, it would be sufficient to launch the business. But, instead, I found that a company can only exist because there is a team of people who have an interest in it existing." Read post
Company News